Samumed to Present Data on Multiple Product Candidates in Five Presentations at The Orthobiologic Institute (TOBI) 2018 Annual ...
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt signaling pathway research and development, today announced that it will present clinical and pre-clinical data on its small molecule investigational drugs for the treatment of …